Criteria set by NQF, CDC, AHRQ
Does anyone take this criteria into consideration whey querying for CAUTI, CLABSI, etc?
With the implementation of the Value-Based Purchasing (VBP) Program, Hospital-Acquired Condition (HAC) Reduction Program, and the list of Hospital-Acquired Conditions (HAC), CDI efforts must focus on documentation implications beyond individual MS-DRG or APR-DRG optimization. Specific criteria established by the National Quality Forum (NQF), Agency for Healthcare Research and Quality (AHRQ), and United States Centers for Disease Control and Prevention (CDC) should be applied when requesting clarification. **Forms with implications set forth in these initiatives (e.g., CAUTI, CLABSI) should be evaluated to avoid the unintended consequences of documentation (e.g., linking sepsis to a central line when the CDC criteria are not met). For example, if the organism from the blood culture and another source (e.g., urine, wound, etc.) match, it is not a CLABSI as defined by the CDC.